Search

Your search keyword '"Soler, G."' showing total 56 results

Search Constraints

Start Over You searched for: Author "Soler, G." Remove constraint Author: "Soler, G." Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
56 results on '"Soler, G."'

Search Results

2. AB0680 LONG-TERM SAFETY EVALUATION IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH TNFi VS JAKi DRUGS IN CLINICAL PRACTICE: RESULTS FROM A LOCAL REGISTRY

3. Global disparities in surgeons’ workloads, academic engagement and rest periods: the on-calL shIft fOr geNEral SurgeonS (LIONESS) study

4. Cetacean distribution and relative abundance in Colombia’s Pacific EEZ from survey cruises and platforms of opportunity

5. POS0168 IMPACT OF THE HYDROXYCHLOROQUINE LEVEL ON THE ECG QT INTERVAL IN PATIENTS WITH SYSTEMIC RHEUMATIC AUTOIMMUNE DISEASES: A REAL-LIFE STUDY

7. OP0229 CHANGES IN THE CAUSES AND PREDICTORS OF LUPUS MORTALITY IN SPAIN THROUGH THE LAST DECADES: DATA FROM THE RELESSER REGISTRY

8. AB1774-HPR SAFETY OF THE RECOMBINANT HERPES ZOSTER VACCINE IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH JAKI DRUGS

11. Prediction of Survival Using the Geriatric Screening Tool in a Prospective Series of Elderly Patients with Colon Cancer

12. PO.7.155 Study of the comorbidities present in the patients included in the registry of systemic lupus erythematosus of the spanish society of rheumatology (relesser)

13. S09.3 Changes in the causes and predictors of lupus mortality in Spain through the last decades: data from the relesser registry

14. POS0369 IMPACT OF HYDROXYCHLOROQUINE LEVEL ON ECG QTC INTERVAL IN PATIENTS WITH RHEUMATIC SYSTEMIC AUTOIMMUNE DISEASES: A REAL-LIFE STUDY

15. AB1023 CHARACTERISTICS OF PATIENTS REFERRED FOR FIRST BONE DENSITOMETRY TO A RHEUMATOLOGY FLS, WITH NORMAL RESULTS IN THE LUMBAR SPINE

17. POS0657 SURVIVAL OF BARICITINIB VS ANTI-TNF AS THE FIRST BIOLOGICAL DRUG IN PATIENTS WITH RHEUMATOID ARTHRITIS, IN CLINICAL PRACTICE: RESULTS OF A LOCAL REGISTRY

20. OP0229 CHANGES IN THE CAUSES AND PREDICTORS OF LUPUS MORTALITY IN SPAIN THROUGH THE LAST DECADES: DATA FROM THE RELESSER REGISTRY

22. CHANGES IN THE CAUSES AND PREDICTORS OF LUPUS MORTALITY IN SPAIN THROUGH THE LAST DECADES: DATA FROM THE RELESSER REGISTRY.

26. Physical Activity Barriers and Facilitators for Older Women With Mild Cognitive Impairment and Alzheimer's Disease.

27. Impact of Treatment With Trifluridine/Tipiracil in Combination With Bevacizumab on Health-Related Quality of Life and Performance Status in Refractory Metastatic Colorectal Cancer: An Analysis of the Phase III SUNLIGHT Trial.

28. Evaluating low back pain through electrodermal activity: a systematic review protocol.

29. Assessing the Prognostic Value of Cytoplasmic and Stromal Caveolin-1 in Early Triple-Negative Breast Cancer Undergoing Neoadjuvant Chemotherapy.

30. Deciphering HER2-low breast cancer (BC): insights from real-world data in early stage breast cancer.

31. Molecular landscape of mature B-cell lymphoproliferative disorders with BCL3-translocation: A Groupe Francophone de Cytogénétique Hématologique (GFCH)/French Innovative Leukemia Organization (FILO) study.

32. [Adrenocortical oncocytoma: 3 case reports].

33. Changes In Serum CXCL13 Levels Are Associated With Outcomes of Colorectal Cancer Patients Undergoing First-Line Oxaliplatin-Based Treatment.

34. Lumbo-Pelvic Rhythm Monitoring Using Wearable Technology with Sensory Biofeedback: A Systematic Review.

35. Is Acute Lower Back Pain Associated with Heart Rate Variability Changes? A Protocol for Systematic Reviews.

36. Climate-driven global redistribution of an ocean giant predicts increased threat from shipping.

37. Effect of Liraglutide in Different Abdominal Fat Layers Measured by Ultrasound: The Importance of Perirenal Fat Reduction.

39. Feasibility of Optical Genome Mapping from Placental and Umbilical Cord Sampled after Spontaneous or Therapeutic Pregnancy Termination.

40. Optical genome mapping for prenatal diagnosis: A prospective study.

41. Magnetic resonance imaging as a predictor of therapeutic response to pasireotide in acromegaly.

42. Genomically matched therapy in refractory colorectal cancer according to ESMO Scale for Clinical Actionability of Molecular Targets: experience of a comprehensive cancer centre network.

43. Parietex™ Composite Ventral Patch for primary and incisional hernia repair.

45. Optical Genome Mapping in Routine Cytogenetic Diagnosis of Acute Leukemia.

46. Central nervous system involvement in systemic lupus erythematosus: Data from the Spanish Society of Rheumatology Lupus Register (RELESSER).

47. Development and in vivo validation of small interfering RNAs targeting NOX3 to prevent sensorineural hearing loss.

48. WNT Activation and TGFβ-Smad Inhibition Potentiate Stemness of Mammalian Auditory Neuroprogenitors for High-Throughput Generation of Functional Auditory Neurons In Vitro.

49. Global collision-risk hotspots of marine traffic and the world's largest fish, the whale shark.

50. SEOM-GECOD clinical guideline for unknown primary cancer (2021).

Catalog

Books, media, physical & digital resources